Funding for this research was provided by:
Text and Data Mining valid from 2017-08-05
Received: 18 March 2017
Accepted: 21 July 2017
First Online: 5 August 2017
Compliance with ethical standards
: This study was funded by Mito BioPharm.
: S.J. is a founder of Mito BioPharm, which has licensed the patents surrounding the development of chemical mitochondrial uncouplers, including niclosamide ethanolamine and niclosamide piperazine (described here), for treating metabolic diseases.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.